FGF21 variant, fusion protein and application thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11679143
APP PUB NO 20210196794A1
SERIAL NO

16960254

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A fibroblast growth factor 21 (FGF21) variant, further to a FGF21 variant fusion protein, a protein multimer, and use thereof can significantly improve the binding ability with the target and can be used to treat metabolic diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • SUNSHINE LAKE PHARMA CO., LTD

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Chao Dongguan, CN 406 6550
Chen, Xiaofeng Dongguan, CN 56 281
Fu, Zheng Dongguan, CN 10 1
Li, Wenjia Dongguan, CN 18 7
Li, Yu Dongguan, CN 349 2891
Lin, Shushan Dongguan, CN 6 1
Liu, Liang Dongguan, CN 751 9326

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Dec 20, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 20, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 20, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00